« FDA Statement on Foodborne E. coli O157:H7 Outbreak in Spinach--Update: | Main | FDA Approvals - More brand-name drug patents expiring (Honolulu Advertiser) WICHITA, Kan. »

FDA Approvals - Chembio Diagnostics to Present at 2006 C.E. Unterberg, Towbin Life


Chembio Diagnostics to Present at 2006 C.E. Unterberg, Towbin Life Sciences Conference on October 31, 2006 (Business Wire via Yahoo! Finance)
NEW YORK----Chembio Diagnostics, Inc.'s Chairman and President, Lawrence Siebert, will present at the 2006 C.E. Unterberg, Towbin Life Sciences Conference on Tuesday, October 31st at 3:30 PM at the New York Palace Hotel in New York City.

PURE Bioscience Reports Year End Results (Business Wire via Yahoo! Finance)
SAN DIEGO----PURE Bioscience today reported financial results for the year ended July 31, 2006. Revenues from continuing operations for the fiscal year were $200,400, compared with equivalent revenues of $155,800 in the prior year.

Alfacell Corporation Reports Fourth Quarter and Fiscal Year 2006 Results and Highlights (RedNova)
Alfacell Corporation (Nasdaq: ACEL) today reported financial results and key Company highlights for the fourth quarter and the 2006 fiscal year, ending July 31, 2006.
 

©2006 FDA-News.com. All rights reserved.